TRIM5 and HIV-1 infection: While our STR studies were not intended to mimic a clinically relevant setting, our results may provide an answer as to how human TRIM5, which has historically been considered ineffective as an HIV-1 restriction factor, can confer protection against HIV-1 infection risk in people [9–11].